Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

The effects of low literacy and cognitive impairment on medication adherence in HIV-positive injecting drug users.

Waldrop-Valverde D, Jones DL, Weiss S, Kumar M, Metsch L.

AIDS Care. 2008 Nov;20(10):1202-10. doi: 10.1080/09540120801927017.

PMID:
19012081
2.

Neurocognitive aspects of medication adherence in HIV-positive injecting drug users.

Waldrop-Valverde D, Ownby RL, Wilkie FL, Mack A, Kumar M, Metsch L.

AIDS Behav. 2006 May;10(3):287-97.

PMID:
16485072
3.

Literacy, self-efficacy, and HIV medication adherence.

Wolf MS, Davis TC, Osborn CY, Skripkauskas S, Bennett CL, Makoul G.

Patient Educ Couns. 2007 Feb;65(2):253-60. Epub 2006 Nov 21.

PMID:
17118617
4.

Structure of a cognitive ability battery among HIV+ intravenous drug users evaluated in a study of medication adherence.

Ownby RL, Kumar M, Waldrop-Valverde D.

Int J Neurosci. 2005 Sep;115(9):1259-71.

PMID:
16048805
5.

Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity.

Concha M, Graham NM, Muñoz A, Vlahov D, Royal W 3rd, Updike M, Nance-Sproson T, Selnes OA, McArthur JC.

Am J Epidemiol. 1992 Dec 1;136(11):1338-48.

PMID:
1362630
6.

HIV infection and cognition in intravenous drug users: long-term follow-up.

Selnes OA, Galai N, McArthur JC, Cohn S, Royal W 3rd, Esposito D, Vlahov D.

Neurology. 1997 Jan;48(1):223-30.

PMID:
9008522
7.

Influence of depression and HIV serostatus on the neuropsychological performance of injecting drug users.

Waldrop-Valverde D, Ownby RL, Kumar M.

Psychiatry Clin Neurosci. 2005 Aug;59(4):372-8.

8.

Neurocognition, health-related reading literacy, and numeracy in medication management for HIV infection.

Waldrop-Valverde D, Jones DL, Gould F, Kumar M, Ownby RL.

AIDS Patient Care STDS. 2010 Aug;24(8):477-84. doi: 10.1089/apc.2009.0300.

9.

Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors.

De Ronchi D, Faranca I, Berardi D, Scudellari P, Borderi M, Manfredi R, Fratiglioni L.

Arch Neurol. 2002 May;59(5):812-8.

PMID:
12020265
10.

The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review.

Lovejoy TI, Suhr JA.

J Behav Med. 2009 Oct;32(5):389-405. doi: 10.1007/s10865-009-9212-9. Epub 2009 Mar 17. Review.

PMID:
19291386
11.

Relationship of beta 2 microglobulin and CD4 counts to neuropsychological performance in HIV-1-infected intravenous drug users.

Boccellari AA, Chambers DB, Dilley JW, Shore MD, Tauber MA, Moss AR, Osmond DH.

J Acquir Immune Defic Syndr. 1994 Oct;7(10):1040-9.

PMID:
7916050
12.

Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.

Moore DJ, Blackstone K, Woods SP, Ellis RJ, Atkinson JH, Heaton RK, Grant I; Hnrc Group And The Tmarc Group.

AIDS Care. 2012;24(12):1504-13. doi: 10.1080/09540121.2012.672718. Epub 2012 Apr 24.

13.

Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial.

Weber R, Christen L, Christen S, Tschopp S, Znoj H, Schneider C, Schmitt J, Opravil M, Günthard HF, Ledergerber B; Swiss HIV Cohort Study.

Antivir Ther. 2004 Feb;9(1):85-95.

PMID:
15040540
14.

Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States.

Vanichseni S, Des Jarlais DC, Choopanya K, Friedmann P, Wenston J, Sonchai W, Sotheran JL, Raktham S, Carballo M, Friedman SR.

AIDS. 1993 Jun;7(6):887-91.

PMID:
8363764
15.

The impact of HIV-associated neuropsychological impairment on everyday functioning.

Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I; HNRC Group.

J Int Neuropsychol Soc. 2004 May;10(3):317-31.

PMID:
15147590
16.

Changes in neurocognition and adherence over six months in HIV-infected individuals with cocaine or heroin dependence.

Anderson AM, Higgins MK, Ownby RL, Waldrop-Valverde D.

AIDS Care. 2015;27(3):333-7. doi: 10.1080/09540121.2014.985183. Epub 2014 Dec 6.

17.

Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.

Weber R, Huber M, Rickenbach M, Furrer H, Elzi L, Hirschel B, Cavassini M, Bernasconi E, Schmid P, Ledergerber B; Swiss HIV Cohort Study.

HIV Med. 2009 Aug;10(7):407-16. doi: 10.1111/j.1468-1293.2009.00701.x. Epub 2009 May 26.

18.

Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study.

Glass TR, Battegay M, Cavassini M, De Geest S, Furrer H, Vernazza PL, Hirschel B, Bernasconi E, Rickenbach M, Günthard HF, Bucher HC; Swiss HIV Cohort Study.

J Acquir Immune Defic Syndr. 2010 Jun;54(2):197-203. doi: 10.1097/QAI.0b013e3181ca48bf.

PMID:
20035231
19.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
20.

Functional health literacy, medication-taking self-efficacy and adherence to antiretroviral therapy.

Colbert AM, Sereika SM, Erlen JA.

J Adv Nurs. 2013 Feb;69(2):295-304. doi: 10.1111/j.1365-2648.2012.06007.x. Epub 2012 Apr 11.

PMID:
22489684

Supplemental Content

Support Center